นักวิจัย: Yot Teerawattananon, MD, PhD The ISPOR International Fellowship Award was established in 2006 to recognize key individuals who would contribute to the development of pharmacoeconomics and outcomes research or the use of outcomes research in health care decision in their own country/region.

นักวิจัย: Yot Teerawattananon, MD, PhD Dr. Yot Teerawattananon has received the ISPOR Best Contributed Podium Presentation Award on “Value of Information: An application in health economic evaluation of renal replacement therapy in Thailand” at ISPOR 2nd Asia-Pacific Conference, which was held in Sh

ISPOR 2008 International Fellowship Report: Is it Time to Think Seriously About Making HTA Available in Settings Where There is the Most Need? Yot Teerawattananon Health Intervention and Technology Assessment Program, Department of Health, Ministry of Public Health, Nonthaburi, Thailand Int

In Bhutan, respiratory infections are some of the major causes of morbidity and mortality in children. Pneumonia, an infection of the lungs, is among the top 10 common causes of children’s death in the country. Not only does it impose costs on society that may not be immediately visible (e.g. produ

In response to a lack of cost-effective data on screening and early treatment of diabetes and hypertension in resource-limited settings, a model-based economic evaluation was performed on the World Health Organization (WHO)’s Package of Essential Non-communicable (PEN) disease interventions for prim

Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand Pattara Leelahavarong1*, Yot Teerawattananon1, Pitsaphun Werayingyong1, Chutima Akaleephan2, Nakorn Premsri3, Chawetsan Namwat3, Wiwat Peerapatanapoki

การรักษามะเร็งตับชนิดเอชซีซี ในผู้ป่วยระยะกลางและระยะต้นที่ไม่สามารถรักษาด้วยวิธีผ่าตัดได้ คือการใช้รังสีร่วมรักษากับยาเคมีบำบัดที่เรียกว่าวิธี Transarterial Chemoembolization (TACE) โดยใช้สาร iodized oil fluid injection เป็นตัวนำยาเคมีบำบัดไปทำลายก้อนมะเร็งในเนื้อเยือตับ แต่ที่ผ่านมาสาร iodized oil

Involvement of consumers in health technology assessment activities by INAHTA agencies. David Haileya1, Sophie Werköa2, Rugayah Bakria3, Alun Camerona4, Britta Göhlena5, Susan Mylesa6, Jasmine Pwua7 and Jomkwan Yothasamuta8 For the INAHTA Working Group on Impact of HTA a1 University of Wollong

In September 2016, Bhutan Ministry of Health (MOH) approached HITAP to provide support to conduct an economic evaluation study to introduce PCV in Bhutan. With regards to the request, WHO Bhutan funded 4 of HITAP staffs (3 researchers and 1 project associate) to help conduct the study. This collaborative work between MOH, HITAP and WHO has a work p